...
【24h】

Urticaria: An Evolving Story

机译:荨麻疹:一个不断发展的故事

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic spontaneous urticaria affects nearly 20% of the population. Although it is commonly considered a mast cell-mediated disease, the mechanism of mast cell activation remains a medical mystery. A number of new developments in this field got us quite excited. The demonstration of the presence of an anti-lgE receptor autoantibody and sometimes an anti-lgE autoantibody in serum from urticaria patients suggested an autoimmune mechanism. Although some studies have shown that these autoanti-bodies are more prevalent in patients with severe urticaria, the clinical correlation is not very strong. This is similar to autoantibodies found in rheumatologic disorders. It is possible that the anti-lgE autoantibody primes the mast cells, which require a second trigger for full activation and manifestation of the disease. We need to further understand the specific role of these autoantibodies in pathogenesis. There are a number of tests that detect this autoantibody. We need a standardized approach for optimal detection of the autoantibodies.
机译:慢性自发性荨麻疹影响了近20%的人口。虽然通常被认为是肥大细胞介导的疾病,但桅杆细胞活化机制仍然是医疗谜。这个领域的一些新的发展让我们非常兴奋。来自荨麻疹患者的血清中存在抗LGE受体自身抗体和有时抗LGE Autoalibody的证明表明了一种自身免疫机制。虽然有些研究表明,这些自身体内的患者对严重荨麻疹的患者更普遍,但临床相关性并不是很强。这类似于风湿病疾病中发现的自身抗体。抗LGE Autoalibody可能引用肥大细胞,这需要第二次触发以全激活和疾病的表现。我们需要进一步了解这些自身抗体在发病机制中的具体作用。有许多检测到这种自身antibody的测试。我们需要一种标准化的方法来最佳地检测自身抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号